Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Diabetic neuropathies: classification and management]

G Said1

  • 1Service de Neurologie, Centre Hospitalier Universitaire de Bicêtre, Le Kremlin Bicêtre.

Diabetes & Metabolism
|January 9, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Microstructure and mechanical properties of MgO-stabilized ZrO₂-Al₂O₃ dental composites.

Journal of the mechanical behavior of biomedical materials·2012
Same author

Painful diabetic neuropathy: diagnosis and management.

Diabetes & metabolism·2011
Same author

Sensory loss, pains, motor deficit and axonal regeneration in length-dependent diabetic polyneuropathy.

Journal of neurology·2008
Same author

A brief compound test for assessment of autonomic and sensory-motor dysfunction in familial amyloid polyneuropathy.

Journal of neurology·2007
Same author

Diagnostic pitfalls in sporadic transthyretin familial amyloid polyneuropathy (TTR-FAP).

Neurology·2007
Same author

Estimated prevalence of peripheral neuropathy and associated pain in adults with diabetes in France.

Current medical research and opinion·2007
Same journal

Glucagon-like peptide-1 receptor agonists and risk of pancreaticobiliary cancers in patients with type 2 diabetes: a nationwide cohort study.

Diabetes & metabolism·2026
Same journal

Decreased risk of new-onset osteoporosis in patients with Type 2 diabetes on SGLT-2 inhibitors.

Diabetes & metabolism·2026
Same journal

Two faces of autoimmune hyperinsulinemia: contrasting type B insulin resistance syndrome and exogenous insulin antibody syndrome.

Diabetes & metabolism·2026
Same journal

CGM-based metrics and mortality in older adults living with type 2 diabetes on insulin therapy: a secondary analysis of the HYPOAGE study.

Diabetes & metabolism·2026
Same journal

Persistent burden and management gaps of hypoglycemia in pediatric type 1 diabetes: insights from the Epi-GLUREDIA Study.

Diabetes & metabolism·2026
Same journal

Blood oxygen saturation and its associations with autonomic and peripheral neuropathy in diabetes.

Diabetes & metabolism·2026
See all related articles

Systematic screening for diabetic neuropathy is crucial for preventing foot complications. Early detection through clinical exams and specialist consultation for unusual cases aids in timely management.

Area of Science:

  • Neurology
  • Endocrinology
  • Diabetology

Context:

  • Diabetic patients require systematic detection of asymptomatic neuropathies.
  • Periodic screening for sensory disturbances in the feet is essential.
  • Preventing trophic disorders in diabetic feet is a clinical priority.

Purpose:

  • To outline the essential steps in diagnosing diabetic neuropathy.
  • To guide the diagnostic approach for focal or multifocal neuropathies in diabetic patients.
  • To define when complementary examinations are indicated for diabetic neuropathy.

Summary:

  • Diagnosis of diabetic neuropathy relies primarily on clinical examination.
  • Focal or multifocal neuropathies require investigation similar to non-diabetic patients.

Related Experiment Videos

  • Unusual presentations, such as motor predominance or rapid progression, necessitate specialist evaluation.
  • Complementary tests like electromyography are reserved for atypical cases.

    • Impact:

    • Facilitates early intervention to prevent diabetic foot complications.
    • Improves diagnostic accuracy by differentiating diabetic from non-diabetic neuropathies.
    • Ensures appropriate utilization of diagnostic resources by indicating tests only for atypical forms.